# Phosphodiesterase 5 Inhibitors (PDE5i) (Sildenafil) as Medical Expulsive Therapy in Distal Ureteral Stones

> **NCT02519153** · PHASE4 · UNKNOWN · sponsor: **Mansoura University** · enrollment: 100 (estimated)

## Conditions studied

- Ureteral Stone
- Urolithiasis

## Interventions

- **DRUG:** Sildenafil

## Key facts

- **NCT ID:** NCT02519153
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-07
- **Primary completion:** 2017-08
- **Final completion:** 2017-09
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02519153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02519153, "Phosphodiesterase 5 Inhibitors (PDE5i) (Sildenafil) as Medical Expulsive Therapy in Distal Ureteral Stones". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02519153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*